References
- Alexander, G. C., Kruszewski, S. P., & Webster, D. W. (2012). Rethinking opioid prescribing to protect patient safety and public health. JAMA, 308(18), 1865–1866. https://doi.org/https://doi.org/10.1001/jama.2012.14282
- Barbour, J. S., Jarvis, M. A., & Withers, D. J. (2020). How Geisinger dramatically reduced deaths from opioid use disorder. NEJM Catalyst, 1(2), 1–20. https://doi.org/https://doi.org/10.1056/CAT.20.0018
- Bartoli, F., Carrà, G., Brambilla, G., Carretta, D., Crocamo, C., Neufeind, J., Baldacchino, A., Humphris, G., & Clerici, M. (2014). Association between depression and non-fatal overdoses among drug users: A systematic review and meta-analysis. Drug and Alcohol Dependence, 134, 12–21. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2013.10.007
- Boscarino, J. A., Kirchner, H. L., Pitcavage, J. M., Nadipelli, V. R., Ronquest, N. A., Fitzpatrick, M. H., & Han, J. J. (2016). Factors associated with opioid overdose: A 10-year retrospective study of patients in a large integrated health care system. Substance Abuse and Rehabilitation, 7, 131–141. https://doi.org/https://doi.org/10.2147/SAR.S108302
- Bradizza, C. M., Stasiewicz, P. R., & Paas, N. D. (2006). Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: A review. Clinical Psychology Review, 26(2), 162–178. https://doi.org/https://doi.org/10.1016/j.cpr.2005.11.005
- Campbell, C. I., Bahorik, A. L., VanVeldhuisen, P., Weisner, C., Rubinstein, A. L., & Ray, G. T. (2018). Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system. Preventive Medicine, 110, 31–37. https://doi.org/https://doi.org/10.1016/j.ypmed.2018.01.019
- Carey, D. J., Fetterolf, S. N., Davis, F. D., Faucett, W. A., Kirchner, H. L., Mirshahi, U., Murray, M. F., Smelser, D. T., Gerhard, G. S., & Ledbetter, D. H. (2016). The Geisinger MyCode community health initiative: An electronic health record-linked biobank for precision medicine research. Genetics in Medicine, 18(9), 906–913. https://doi.org/https://doi.org/10.1038/gim.2015.187
- Compton, W. M., Cottler, L. B., Jacobs, J. L., Ben-Abdallah, A., & Spitznagel, E. L. (2003). The role of psychiatric disorders in predicting drug dependence treatment outcomes. The American Journal of Psychiatry, 160(5), 890–895. https://doi.org/https://doi.org/10.1176/appi.ajp.160.5.890
- Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006). Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry, 67(02), 247–258. https://doi.org/https://doi.org/10.4088/JCP.v67n0211
- Curran, G. M., Sullivan, G., Williams, K., Han, X., Allee, E., & Kotrla, K. J. (2008). The association of psychiatric comorbidity and use of the emergency department among persons with substance use disorders: An observational cohort study. BMC Emergency Medicine, 8(1), Article 17. https://doi.org/https://doi.org/10.1186/1471-227X-8-17
- Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR. Recommendations and Reports, 65(1), 1–49. https://doi.org/https://doi.org/10.15585/mmwr.rr6501e1
- Fiest, K. M., Jette, N., Quan, H., St. Germaine-Smith, C., Metcalfe, A., Patten, S. B., & Beck, C. A. (2014). Systematic review and assessment of validated case definitions for depression in administrative data. BMC Psychiatry, 14, Article 289. https://doi.org/https://doi.org/10.1186/s12888-014-0289-5
- Goesling, J., Henry, M. J., Moser, S. E., Rastogi, M., Hassett, A. L., Clauw, D. J., & Brummett, C. M. (2015). Symptoms of depression are associated with opioid use regardless of pain severity and physical functioning among treatment-seeking patients with chronic pain. The Journal of Pain, 16(9), 844–851. https://doi.org/https://doi.org/10.1016/j.jpain.2015.05.010
- Goldner, E. M., Lusted, A., Roerecke, M., Rehm, J., & Fischer, B. (2014). Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: Systematic review and meta-analyses. Addictive Behaviors, 39(3), 520–531. https://doi.org/https://doi.org/10.1016/j.addbeh.2013.11.022
- Grella, C. E., Karno, M. P., Warda, U. S., Niv, N., & Moore, A. A. (2009). Gender and comorbidity among individuals with opioid use disorders in the NESARC study. Addictive Behaviors, 34(6–7), 498–504. https://doi.org/https://doi.org/10.1016/j.addbeh.2009.01.002
- Havard, A., Teesson, M., Darke, S., & Ross, J. (2006). Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment, 30(4), 355–362. https://doi.org/https://doi.org/10.1016/j.jsat.2006.03.012
- Hedegaard, H., Warner, M., & Miniño, A. M. (2017). Drug overdose deaths in the United States, 1999–2015. National Center for Health Statistics Data Brief, No 356. US Department of Health and Human Services. Centers for Disease Control and Prevention.
- Higgins, C., Smith, B. H., & Matthews, K. (2020). Comparison of psychiatric comorbidity in treatment-seeking, opioid-dependent patients with versus without chronic pain. Addiction, 115(2), 249–258. https://doi.org/https://doi.org/10.1111/add.14768
- Hser, Y.-I., Mooney, L. J., Saxon, A. J., Miotto, K., Bell, D. S., & Huang, D. (2017). Chronic pain among patients with opioid use disorder: Results from electronic health records data. Journal of Substance Abuse Treatment, 77, 26–30. https://doi.org/https://doi.org/10.1016/j.jsat.2017.03.006
- Ingram, W. M., Baker, A. M., Bauer, C. R., Brown, J. P., Goes, F. S., Larson, S., & Zandi, P. P. (2020). Defining major depressive disorder cohorts using the EHR: Multiple phenotypes based on ICD-9 codes and medication orders. Neurology, Psychiatry, and Brain Research, 36, 18–26. https://doi.org/https://doi.org/10.1016/j.npbr.2020.02.002
- Jones, C. M., & McCance-Katz, E. F. (2019). Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug and Alcohol Dependence, 197, 78–82. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2018.12.030
- Krawczyk, N., Eisenberg, M., Schneider, K. E., Richards, T. M., Lyons, B. C., Jackson, K., Ferris, L., Weiner, J. P., & Saloner, B. (2020). Predictors of overdose death among high-risk emergency department patients with substance-related encounters: A data linkage cohort study. Annals of Emergency Medicine, 75(1), 1–12. https://doi.org/https://doi.org/10.1016/j.annemergmed.2019.07.014
- Krawczyk, N., Feder, K. A., Saloner, B., Crum, R. M., Kealhofer, M., & Mojtabai, R. (2017). The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample. Drug and Alcohol Dependence, 175, 157–163. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2017.02.006
- Lozano, Ó. M., Rojas, A. J., & Fernández Calderón, F. (2017). Psychiatric comorbidity and severity of dependence on substance users: How it impacts on their health-related quality of life? Journal of Mental Health, 26(2), 119–126. https://doi.org/https://doi.org/10.1080/09638237.2016.1177771
- McGinty, E. E., Stuart, E. A., Caleb Alexander, G., Barry, C. L., Bicket, M. C., & Rutkow, L. (2018). Protocol: Mixed-methods study to evaluate implementation, enforcement, and outcomes of U.S. state laws intended to curb high-risk opioid prescribing. Implementation Science, 13(1), Article 37. https://doi.org/https://doi.org/10.1186/s13012-018-0719-8
- Mojtabai, R., Chen, L.-Y., Kaufmann, C. N., & Crum, R. M. (2014). Comparing barriers to mental health treatment and substance use disorder treatment among individuals with comorbid major depression and substance use disorders. Journal of Substance Abuse Treatment, 46(2), 268–273. https://doi.org/https://doi.org/10.1016/j.jsat.2013.07.012
- Oquendo, M. A., & Volkow, N. D. (2018). Suicide: A silent contributor to opioid-overdose deaths. The New England Journal of Medicine, 378(17), 1567–1569. https://doi.org/https://doi.org/10.1056/NEJMp1801417
- Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA, 264(19), 2511–2518. https://doi.org/https://doi.org/10.1001/jama.1990.03450190043026
- Rosenblum, A., Joseph, H., Fong, C., Kipnis, S., Cleland, C., & Portenoy, R. K. (2003). Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA, 289(18), 2370–2378. https://doi.org/https://doi.org/10.1001/jama.289.18.2370
- Salter, M. L., Lau, B., Go, V. F., Mehta, S. H., & Kirk, G. D. (2011). HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users. Clinical Infectious Diseases, 53(12), 1256–1264. https://doi.org/https://doi.org/10.1093/cid/cir673
- Savant, J. D., Barry, D. T., Cutter, C. J., Joy, M. T., Dinh, A., Schottenfeld, R. S., & Fiellin, D. A. (2013). Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment. Drug and Alcohol Dependence, 127(1–3), 243–247. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2012.06.020
- Simon, G. E., Johnson, E., Lawrence, J. M., Rossom, R. C., Ahmedani, B., Lynch, F. L., Beck, A., Waitzfelder, B., Ziebell, R., Penfold, R. B., & Shortreed, S. M. (2018). Predicting suicide attempts and suicide deaths following outpatient visits using electronic health records. The American Journal of Psychiatry, 175(10), 951–960. https://doi.org/https://doi.org/10.1176/appi.ajp.2018.17101167
- Substance Abuse and Mental Health Services Administration. (2020). Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/
- Tian, T. Y., Zlateva, I., & Anderson, D. R. (2013). Using electronic health records data to identify patients with chronic pain in a primary care setting. Journal of the American Medical Informatics Association, 20(e2), e275–e280. https://doi.org/https://doi.org/10.1136/amiajnl-2013-001856
- Tonelli, M., Wiebe, N., Fortin, M., Guthrie, B., Hemmelgarn, B. R., James, M. T., Klarenbach, S. W., Lewanczuk, R., Manns, B. J., Ronksley, P., Sargious, P., Straus, S., & Quan, H. (2016). Methods for identifying 30 chronic conditions: Application to administrative data. BMC Medical Informatics and Decision Making, 15(1), Article 31. https://doi.org/https://doi.org/10.1186/s12911-015-0155-5
- Walkup, J. T., Townsend, L., Crystal, S., & Olfson, M. (2012). A systematic review of validated methods for identifying suicide or suicidal ideation using administrative or claims data. Pharmacoepidemiology and Drug Safety, 21(S1), 174–182. https://doi.org/https://doi.org/10.1002/pds.2335